International Primary Care Respiratory Group (IPCRG)
This sponsor has funded 2 studies across 7 countries.
This sponsor has funded 2 studies across 7 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 6749 | Finalised | Multi-component assessment systems and predicting future risk in chronic obstructive pulmonary disease | No | No |
| 41519 | Ongoing | The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients | Yes | No |
International Primary Care Respiratory Group (IPCRG)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
International Primary Care Respiratory Group (IPCRG)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
International Primary Care Respiratory Group (IPCRG)
7 Study countries specified are the following: